These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 5142139

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.
    Mettler FP, Young DM, Ward JM.
    Cancer Res; 1977 Aug; 37(8 Pt 1):2705-13. PubMed ID: 872096
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)].
    Rizzari C, Santamaria M, Galli MA, Jankovic M, Uderzo C.
    Pediatr Med Chir; 1987 Aug; 9(6):749-50. PubMed ID: 3481847
    [Abstract] [Full Text] [Related]

  • 28. [Cardiotoxic effects of drugs and various other substances. A review].
    Mono G, Kuhn E.
    Fortschr Med; 1978 Apr 13; 96(14):765-70. PubMed ID: 25235
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Osseous changes and abnormalities of mineral metabolism in daunomycin rats.
    Shimizu K, Maeda K, Shibata M, Ise M, Sugano M, Uehara Y.
    Nihon Jinzo Gakkai Shi; 1990 Aug 13; 32(8):863-9. PubMed ID: 2250403
    [Abstract] [Full Text] [Related]

  • 31. [Polycardiographic evaluation of cardiotoxic effects of rubidomycin in patients with acute leukemia].
    Wodniecki J, Prochaczek F, Holowiecki J, Stella B.
    Acta Haematol Pol; 1976 Aug 13; 7(3):195-8. PubMed ID: 983667
    [Abstract] [Full Text] [Related]

  • 32. [Pathological anatomy in heart insufficiency].
    Meessen H.
    Arztl Forsch; 1967 Feb 10; 21(2):41-50. PubMed ID: 4873357
    [No Abstract] [Full Text] [Related]

  • 33. Daunorubicin-induced cardiotoxicity.
    Morgan OS, Amin UF, Gibbs WN.
    West Indian Med J; 1976 Mar 10; 25(1):58-63. PubMed ID: 1266211
    [No Abstract] [Full Text] [Related]

  • 34. Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat.
    Dziegiel P, Jethon Z, Suder E, Sopel M, Rabczyński J, Surowiak P, Zabel M.
    Exp Toxicol Pathol; 2002 Feb 10; 53(6):433-9. PubMed ID: 11926284
    [Abstract] [Full Text] [Related]

  • 35. Pathologic changes induced by daunomycin (NSC-82151) in the Syrian golden hamster.
    Farmar RM, Herman EH, Schein P.
    Cancer Chemother Rep; 1970 Feb 10; 54(1):15-22. PubMed ID: 5527011
    [No Abstract] [Full Text] [Related]

  • 36. Daunomycin.
    IARC Monogr Eval Carcinog Risk Chem Man; 1976 Feb 10; 10():145-52. PubMed ID: 791796
    [No Abstract] [Full Text] [Related]

  • 37. [Cardiotoxicity of rubidomycin. Anatomo-clinical study of 1 case].
    Fontaine JL, Bonnet-Gajdos M, Mougenot B.
    Arch Fr Pediatr; 1974 Feb 10; 31(7):697-704. PubMed ID: 4531839
    [No Abstract] [Full Text] [Related]

  • 38. Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats.
    Arozal W, Watanabe K, Veeraveedu PT, Thandavarayan RA, Harima M, Sukumaran V, Suzuki K, Tachikawa H, Kodama M, Aizawa Y.
    Free Radic Res; 2010 Nov 10; 44(11):1369-77. PubMed ID: 20815778
    [Abstract] [Full Text] [Related]

  • 39. [Cardiac insufficiency caused by the use of daunorubicin. Clinical and developmental study of 4 recent cases].
    Bauters F, Plouvier B, Breviere G, Goudemand M.
    Sem Hop; 1975 Jun 14; 51(28):1949-57. PubMed ID: 180611
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.